Atlas Trials

Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors

Clinical trial NCT02897986 · UNKNOWN

Trial details

NCT number
NCT02897986
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric Cancer
Start date
2017-01-01
Primary completion
2020-01-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.